These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844 [TBL] [Abstract][Full Text] [Related]
10. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma. Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139 [TBL] [Abstract][Full Text] [Related]
11. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence]. Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680 [TBL] [Abstract][Full Text] [Related]
12. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia. Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470 [TBL] [Abstract][Full Text] [Related]
13. Barrett's metaplasia develops from cellular reprograming of esophageal squamous epithelium due to gastroesophageal reflux. Minacapelli CD; Bajpai M; Geng X; Cheng CL; Chouthai AA; Souza R; Spechler SJ; Das KM Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G615-G622. PubMed ID: 28336546 [TBL] [Abstract][Full Text] [Related]
14. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma. Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377 [TBL] [Abstract][Full Text] [Related]
15. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma. Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730 [TBL] [Abstract][Full Text] [Related]
16. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma. Schlottmann F; Molena D; Patti MG Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus. Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310 [TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175 [TBL] [Abstract][Full Text] [Related]
19. Insights Into the Pathophysiology of Esophageal Adenocarcinoma. Quante M; Graham TA; Jansen M Gastroenterology; 2018 Jan; 154(2):406-420. PubMed ID: 29037468 [TBL] [Abstract][Full Text] [Related]
20. The diagnosis and management of Barrett's esophagus. DeMeester SR; DeMeester TR Adv Surg; 1999; 33():29-68. PubMed ID: 10572561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]